Research-backed firm
Investment research
for everyone.
Professional investors rely on qualified equity research to inform their decisions. We provide the same research for individual investors.
About Investment Reports
In finance, investment reports are the core of many investment decisions for professional investors.
-
Fundamentals
Evaluate a firm’s financials and risks for lasting stability and growth prospects.
-
Valuation
Offer an accurate asset valuation, helping spot market opportunities.
-
Scenarios
Detail scenarios for varied market conditions to navigate uncertainty.
52 Week Range
Target Upside
Company Coverage
Download out sample research report to review
the problams
Investment reports are
priced for institutions.
Mean annual price +120’000$
Solution
We believe professional research should be accessible to everyone.
We publish investment reports on selected publicly traded companies, following our proprietary research methodology.
About ELAM1
ELAM1 is a Switzerland-registered equity research firm specializing in healthcare and biotechnology. With more than 15 years of experience, we assist financial professionals to invest in the healthcare and biotechnology sectors.
15+
Years of Experience in Finance
Global
Clients: USA, UAE, Switzerland, France
CHE
Registered Research Firm in Switzerland
Michael Brandt
Equity Research Lead
Susan Wu
Portfolio Strategy Lead
Isabelle Schmidt
Quantitative Research Lead
David Chen
Investment Solutions Lead
The Institutional Standard
Large banks are required to cover entire markets.
The Institutional Standard
Large banks are required to cover entire markets.